title: Basiliximab for the treatment of graft rejection in haploidentical peripheral blood stem cell transplantation.
authors.affiliation: Centro Trapianti di Midollo Osseo e Terapia Sovramassimali Emato-Oncologiche Alberto Neri, Azienda Ospedaliera Bianchi-melacrino-morelli, Reggio Calabria, Italy. gspmessina@virgilio.it
authors.forename: G
authors.initials: G
authors.lastname: Messina
authors.forename: E
authors.initials: E
authors.lastname: Quartarone
authors.forename: M
authors.initials: M
authors.lastname: Fujo
authors.forename: G
authors.initials: G
authors.lastname: Irrera
authors.forename: G
authors.initials: G
authors.lastname: Console
authors.forename: M
authors.initials: M
authors.lastname: Martino
authors.forename: R
authors.initials: R
authors.lastname: Mandaglio
authors.forename: F
authors.initials: F
authors.lastname: Morabito
authors.forename: P
authors.initials: P
authors.lastname: Iacopino
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D000077552:Basiliximab; D006084:Graft Rejection / Q000188:drug therapy*; D006239:Haplotypes; D006648:Histocompatibility; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D015470:Leukemia, Myeloid, Acute / Q000628:therapy; D015479:Leukemia, Myelomonocytic, Acute / Q000628:therapy; D008297:Male; D036102:Peripheral Blood Stem Cell Transplantation / Q000009:adverse effects*; D011993:Recombinant Fusion Proteins; D014184:Transplantation, Homologous / Q000276:immunology
chemical_list: D000911:Antibodies, Monoclonal; D007166:Immunosuppressive Agents; D011993:Recombinant Fusion Proteins; D000077552:Basiliximab